The effect of food on the oral administration of 6-mercaptopurine. 1986

N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister

The effect of food on the bioavailability of 6-mercaptopurine (6-MP) has been investigated. Seven patients were studied on two separate occasions. On the first occasion 6-MP was administered p.o. after an overnight fast and on the second, 15 min after a standard breakfast. 6-MP concentrations were determined by high-performance liquid chromatography. Variable plasma drug levels were observed between individual subjects in the fasting state. The peak levels of 6-MP were lower and took longer to be achieved following administration after a standard breakfast than after an overnight fast. In two subjects levels were undetectable (less than 20 ng/ml). In view of these observations it is suggested that 6-MP should be administered before food if maximum blood levels are to be achieved.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H

Related Publications

N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
April 1987, Clinical pharmacology and therapeutics,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
January 1981, Chemical & pharmaceutical bulletin,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
January 1963, Comptes rendus des seances de la Societe de biologie et de ses filiales,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
May 1962, The American journal of pathology,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
December 2007, Bioorganic & medicinal chemistry letters,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
October 1973, Transplantation,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
June 1968, The Australian journal of experimental biology and medical science,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
October 1966, Bulletin of the Calcutta School of Tropical Medicine,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
January 1955, Giornale italiano di chemioterapia,
N K Burton, and M J Barnett, and G W Aherne, and J Evans, and I Douglas, and T A Lister
August 1965, The Journal of clinical investigation,
Copied contents to your clipboard!